| AMN Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026 |
Globe Newswire |
04/09 |
07:30 |
| Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline |
Globe Newswire |
04/09 |
07:30 |
| EarthDaily Secures Eight-Figure AI-Ready Data Subscription Agreement with US Defense & Intelligence Technology Company |
Globe Newswire |
04/09 |
07:30 |
| Bitcoin Bancorp Launches California Deployment of Licensed Bitcoin ATM Network With First Installations |
Globe Newswire |
04/09 |
07:30 |
| Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,* |
Globe Newswire |
04/09 |
07:30 |
| Weight Watchers Announces Board Committee Appointments |
Globe Newswire |
04/09 |
07:30 |
| Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles |
Globe Newswire |
04/09 |
07:01 |
| Click Therapeutics and Boehringer Ingelheim Announce Series D Investment and Funding to Advance Commercialization of CT-155 |
Globe Newswire |
04/09 |
07:00 |
| Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th |
Globe Newswire |
04/09 |
07:00 |
| Sigma Automate Emerges from Stealth with $2.75M in Funding to Close the Enterprise IT Automation Gap |
Globe Newswire |
04/09 |
07:00 |
| The Simply Good Foods Company Reports Fiscal Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Outlook |
Globe Newswire |
04/09 |
07:00 |
| Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting |
Globe Newswire |
04/09 |
07:00 |
| Aurora Mobile Debuts Modellix: A Unified Gateway for Next-Gen AI Media Generation |
Globe Newswire |
04/09 |
07:00 |
| Oxford BioTherapeutics Enters Strategic Collaboration with Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours |
Globe Newswire |
04/09 |
07:00 |
| Deal Technology Evaluation Has Shifted for Enterprise Teams |
Globe Newswire |
04/09 |
07:00 |
| Occidental Announces Gulf of America Oil Discovery at Bandit |
Globe Newswire |
04/09 |
07:00 |
| Seres Therapeutics to Present at CARB-X Investor Day |
Globe Newswire |
04/09 |
07:00 |
| Capstreet-backed TradePending Announces Executive Appointments |
Globe Newswire |
04/09 |
07:00 |
| PyroGenesis Announces Contract Toward Titanium Powder Supply and Distribution Agreement with Asian Materials Company |
Globe Newswire |
04/09 |
07:00 |
| Mvix Launches Secure Power BI GCC and GCC High Integration for Government Digital Signage |
Globe Newswire |
04/09 |
07:00 |
| Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate |
Globe Newswire |
04/09 |
07:00 |
| Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy |
Globe Newswire |
04/09 |
07:00 |
| C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs) |
Globe Newswire |
04/09 |
06:59 |
| B2BROKER Group Expands B2COPY into a Scalable Multi-Server Copy Trading Infrastructure with Transparent Pricing |
Globe Newswire |
04/09 |
06:50 |
| Everything Blockchain (OTC: EBZT) Acquires 10% Stake in NoLimit Foundation |
Globe Newswire |
04/09 |
06:50 |
